Walker v. Pharmaceutical Research & Manufacturers of America

569 F. Supp. 2d 209, 44 Employee Benefits Cas. (BNA) 2880, 2008 U.S. Dist. LEXIS 59947, 2008 WL 3090305
CourtDistrict Court, District of Columbia
DecidedAugust 7, 2008
DocketCivil Action 04-1991 (RMU)
StatusPublished
Cited by6 cases

This text of 569 F. Supp. 2d 209 (Walker v. Pharmaceutical Research & Manufacturers of America) is published on Counsel Stack Legal Research, covering District Court, District of Columbia primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Walker v. Pharmaceutical Research & Manufacturers of America, 569 F. Supp. 2d 209, 44 Employee Benefits Cas. (BNA) 2880, 2008 U.S. Dist. LEXIS 59947, 2008 WL 3090305 (D.D.C. 2008).

Opinion

MEMORANDUM OPINION

Granting in Part and Denying in part the Individual Defendants’ Motion to Dismiss; Granting in Part and Denying in Part the New York Life Defendants’ Motion for Summary Judgment

RICARDO M. URBINA, District Judge.

I. INTRODUCTION

The remaining defendants in this lengthy litigious saga set before this court a motion to dismiss and a motion for summary judgment. Individuals who are current or former members of the board of directors of Pharmaceutical Research and Manufacturers of America 1 (“PhRMA”) and members of the PhRMA retirement committee (collectively the “individual defendants”) filed the motion to dismiss. New York Life Insurance Company (“NYLIC”) and New York Life Investment Management, Inc. (“NYLIM”) (collectively the “New York Life defendants”) filed the motion for summary judgment. Both groups of defendants raise numerous arguments against the plaintiffs claims, which stem from alleged violations of the Employee Retirement Income Security Act of 1974 (“ERISA”), 29 U.S.C. §§ 1001 et seq. Because the plaintiff failed to properly serve 10 of the individual defendants, the court allows 30 days for the plaintiff, proceeding pro se, to properly effect service. Furthermore, because claims arising before November 15, 1998 are definitively time barred, and because the plaintiff may not re-hash old legal arguments to bring back claims that this court previously dismissed, the court dismisses many of the plaintiffs ERISA claims. But, the court does not dismiss the plaintiffs claims that allege that the remaining defendants failed to respond to requests for, or disclose, ERISA plan documents in more recent years.

II. BACKGROUND

A. Factual Background

The plaintiff, an attorney, was a full-time employee of PhRMA in various professional capacities from 1977 to 1988. Mem. Op. (July 17, 2006), 439 F.Supp.2d 103, 105. Following the birth of her second child in 1988, the plaintiff requested but *212 was denied a part-time work arrangement because PhRMA’s then-president “did not believe in part-time professionals.” Id. Instead, PhRMA’s General Counsel, Bruce Brennan, suggested that the plaintiff serve as an independent contractor. Id. The plaintiff accepted this arrangement and signed an independent contractor agreement on March 24, 1988. 2 Id. At the expiration of that agreement, the plaintiff and PhRMA signed identically worded agreements every year until 2001. Id. at 105-06. The final agreement, signed on September 12, 2001, notified the plaintiff that PhRMA did not intend to continue their relationship following the expiration of the agreement on June 30, 2002. Id.

The independent contractor agreements signed by the plaintiff each year stated that the plaintiff “shall be engaged as an independent contractor, not as an employee, and shall not be entitled to participate in any of [PhRMA’s] employee benefit plans.” Id. at 105. The plaintiff alleges that she signed the independent contractor agreements based on the belief that part-time employees, like independent contractors, were ineligible for employee benefits. Id. at 105. In other words, the plaintiff alleges that she “had no reason” to challenge her classification as an independent contractor rather than as a part-time employee because she believed the “terms and conditions of her employment” were the same as those of part-time employees. Pis.’ Mot. to Ater or Amend J. at 5.

Sometime between 1991 and 1994, PhRMA reinterpreted its retirement plan to make part-time employees eligible for certain retirement benefits. Id. at 5. The plaintiff alleges that the defendants violated ERISA because they failed to notify independent contractors of the changes affecting part-time employees. Id. at 5, 13, 16.

B. Procedural Background

The plaintiff filed her original complaint on November 11, 2004, and she amended her complaint in August 2005. Athough difficult to parse, the complaint appears to assert the following claims arising under ERISA 3 : (1) that the plaintiff is entitled to benefits under 29 U.S.C. § 1132(a)(1)(B) (“ERISA § 502”); (2) that the defendants interfered with her rights to retirement benefits by improperly classifying her as an independent contractor, in violation of 29 U.S.C. § 1140 (“ERISA § 510”); and (3) that the defendants breached their fiduciary duties by either failing to notify the plaintiff that part-time employees were eligible to receive benefits, or by classifying her as an independent contractor, rather than as a part-time employee, in violation of 29 U.S.C. § 1104 (“ERISA § 404”).

The PhRMA defendants 4 moved for summary judgment in October 2005 on the grounds that the statute of limitations bars the plaintiffs ERISA claims and that ERISA preempts the plaintiffs common law claims. See generally PhRMA’s Mot. In granting the PhRMA defendants’ motion on July 17, 2006, the court determined that (1) the three-year statute of limitations bars the plaintiffs § 502 claim be *213 cause it began to run when the parties executed an independent contractor agreement in 1988; (2) applying either a one-year or a three-year statute of limitation would bar the plaintiffs § 510 claim because the claim accrued in 1988, the year she learned that she was no longer eligible to participate in the PhRMA retirement plans; (3) the statute of limitations bars the plaintiffs § 404 claim because the plaintiff had knowledge of the alleged breach or violation more than three years before she filed suit; and (4) ERISA preempts the plaintiffs D.C. common law claims. See generally Mem. Op. (July 16, 2006).

The plaintiff then filed a motion to alter or amend judgment on July 31, 2006. The court denied the plaintiffs motion, reaffirming the dismissal of each of the plaintiffs claims. The court explained that the plaintiffs § 502 claim accrued the date of the clear repudiation of benefits, not, as the plaintiff argued in her motion, the date the defendants denied the plaintiffs claim for benefits. Mem. Op. (Nov. 15, 2006), 461 F.Supp.2d 52, 56-57. The court then rejected the plaintiffs argument that her waiver of benefits could not have been clear without the knowledge that part-time employees were entitled to benefits. Id. at 57. In rejecting this argument, the court reasoned that the repudiation of benefits is the communication at issue, not communications regarding other employees’ benefits. Id.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Marcin v. Reliance Standard Life Insurance Company
50 F. Supp. 3d 23 (District of Columbia, 2014)
Walker v. Pharmaceutical Research & Manufacturers of America
827 F. Supp. 2d 8 (District of Columbia, 2011)
Constien v. United States
628 F.3d 1207 (Tenth Circuit, 2010)
Olivo v. ELKY
646 F. Supp. 2d 95 (District of Columbia, 2009)

Cite This Page — Counsel Stack

Bluebook (online)
569 F. Supp. 2d 209, 44 Employee Benefits Cas. (BNA) 2880, 2008 U.S. Dist. LEXIS 59947, 2008 WL 3090305, Counsel Stack Legal Research, https://law.counselstack.com/opinion/walker-v-pharmaceutical-research-manufacturers-of-america-dcd-2008.